| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 236 Employees | - Last Dividend | 13 Dec 2023 Last Split | - IPO Date |
Founded in 2000 and headquartered in Jinju-si, South Korea, Amicogen, Inc. stands out as an industrial biotechnology company with an international presence. It is dedicated to innovating within the biotechnology sector by focusing on the development and commercialization of a wide array of specialty enzymes and new bio-ingredients tailored for various industries including pharmaceutical, food, chemical, and energy sectors. Amicogen leverages cutting-edge biotechnological advancements to create products designed for enhancing health and industrial processes. The company’s commitment to research and development ensures the continuous creation of high-quality, efficacious products that cater to global market needs.